928
Views
45
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Germany from a large insurance-based regional cohort

, , &
Pages 1325-1335 | Received 12 May 2014, Accepted 24 Aug 2014, Published online: 26 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mira Y Friedman, Maya Leventer-Roberts, Joseph Rosenblum, Nir Zigman, Iris Goren, Vered Mourad, Natan Lederman, Nurit Cohen, Eran Matz, Doron Z Dushnitzky, Nirit Borovsky, Moshe B Hoshen, Gili Focht, Malka Avitzour, Yael Shachar, Yehuda Chowers, Rami Eliakim, Shomron Ben-Horin, Shmuel Odes, Doron Schwartz, Iris Dotan, Eran Israeli, Zohar Levi, Eric I Benchimol, Ran D Balicer & Dan Turner. (2018) Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clinical Epidemiology 10, pages 671-681.
Read now

Articles from other publishers (44)

Gabriela Riemekasten, Renate Schmelz, Knut Schäkel, Diamant Thaci, Stefan Schreiber, Marit Röcken, Holger Bartz, Tina Ploner, Ximing Liao, Valeria Weber, Karina C. Manz, Harald Burkhardt & Jan Leipe. (2023) Epidemiologische Daten und medizinische Versorgungssituation von Patienten mit chronischen Entzündungserkrankungen in DeutschlandEpidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany. Zeitschrift für Rheumatologie.
Crossref
Alexandra J. Noble, Jan K. Nowak, Alex T. Adams, Holm H. Uhlig & Jack Satsangi. (2023) Defining Interactions Between the Genome, Epigenome, and the Environment in Inflammatory Bowel Disease: Progress and Prospects. Gastroenterology 165:1, pages 44-60.e2.
Crossref
Isa Maria Steiner, Bernd Bokemeyer & Tom Stargardt. (2023) Mapping from SIBDQ to EQ-5D-5L for patients with inflammatory bowel disease. The European Journal of Health Economics.
Crossref
Adnan Fayadh Sameer. (2023) Investigation of Crohn's Disease by Immunohistochemistry Technique in Iraqi Patients. Bionatura 8:2, pages 1-12.
Crossref
Zsuzsanna Kurti, Lorant Gonczi, Laszlo Lakatos, Petra A Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita & Peter L Lakatos. (2023) Epidemiology, Treatment Strategy, Natural Disease Course and Surgical Outcomes of Patients with Ulcerative Colitis in Western Hungary – A Population-based Study Between 2007 and 2018: Data from the Veszprem County Cohort. Journal of Crohn's and Colitis 17:3, pages 352-360.
Crossref
Jörg C. Hoffmann & Jörg Edelmann. (2023) Therapieupdate 2022: Colitis ulcerosaTreatment update 2022: ulcerative colitis. Wiener klinisches Magazin 26:2, pages 58-65.
Crossref
Lorant Gonczi, Laszlo Lakatos, Zsuzsanna Kurti, Petra A Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita & Peter L Lakatos. (2023) Incidence, Prevalence, Disease Course, and Treatment Strategy of Crohn’s Disease Patients from the Veszprem Cohort, Western Hungary: A Population-based Inception Cohort Study Between 2007 and 2018. Journal of Crohn's and Colitis 17:2, pages 240-248.
Crossref
Jörg C. Hoffmann & Jörg Edelmann. (2023) Therapieupdate 2022: Colitis ulcerosaTreatment update 2022: ulcerative colitis. Die Gastroenterologie 18:1, pages 54-63.
Crossref
Valentina Strohmeier, Geoffroy Andrieux, Susanne Unger, Anna Pascual-Reguant, Adam Klocperk, Maximilian Seidl, Otavio Cabral Marques, Marleen Eckert, Katja Gräwe, Michelle Shabani, Caroline von Spee-Mayer, David Friedmann, Ina Harder, Sylvia Gutenberger, Baerbel Keller, Michele Proietti, Alla Bulashevska, Bodo Grimbacher, Jan Provaznik, Vladimir Benes, Sigune Goldacker, Christoph Schell, Anja E. Hauser, Melanie Boerries, Peter Hasselblatt & Klaus Warnatz. (2022) Interferon-Driven Immune Dysregulation in Common Variable Immunodeficiency–Associated Villous Atrophy and Norovirus Infection. Journal of Clinical Immunology 43:2, pages 371-390.
Crossref
. 2023. Schmerzbuch Physiotherapie. Schmerzbuch Physiotherapie 269 293 .
Kristian Ekström. 2023. Schmerzbuch Physiotherapie. Schmerzbuch Physiotherapie 249 267 .
Karsten Keller, Visvakanth Sivanathan, Volker H. Schmitt, Mir A. Ostad, Thomas Münzel, Christine Espinola-Klein & Lukas Hobohm. (2022) Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease. Thrombosis Research 219, pages 77-85.
Crossref
Adnan Fayadh Sameer, Abed Hassan Barraj & Hayder Jamaal Mahmood. (2022) NOD1/CARD4(G796A) and NOD2/CARD15(R702W, G908R and L1007fsinC) polymorphisms associated with Crohn's disease in Iraqi patients. Bionatura 7:3, pages 1-8.
Crossref
Stefan Schubert, Nils Picker, Taner Cavlar, Jana Knop, Alisan Kahraman & Wolfgang Mohl. (2022) Inflammatory Bowel Disease Patients’ Treatment Preferences Using a Discrete Choice Experiment Technique: The InPuT Study. Advances in Therapy 39:6, pages 2889-2905.
Crossref
Nikolaos Kyriakos, Apostolis Papaefthymiou, Marios Giakoumis, Michail Galanopoulos, Petros Galanis, Iordanis Mylonas, Pantelis Karatzas, Gerasimos Mantzaris & Christos Liatsos. (2021) Prevalence of inflammatory bowel disease in young Greek Army male recruits from 2006 to 2018: a 13-year retrospective study from a tertiary center. European Journal of Gastroenterology & Hepatology 34:2, pages 153-160.
Crossref
Mira Y Stulman, Noa Asayag, Gili Focht, Ilan Brufman, Amos Cahan, Natan Ledderman, Eran Matz, Yehuda Chowers, Rami Eliakim, Shomron Ben-Horin, Shmuel Odes, Iris Dotan, Ran D Balicer, Eric I Benchimol & Dan Turner. (2021) Epidemiology of Inflammatory Bowel Diseases in Israel: A Nationwide Epi-Israeli IBD Research Nucleus Study. Inflammatory Bowel Diseases 27:11, pages 1784-1794.
Crossref
Tanja Neufeld, Katrin Pfuhlmann, Beate Stock-Schröer, Lana Kairey, Nina Bauer, Winfried Häuser & Jost Langhorst. (2021) Cannabis use of patients with inflammatory bowel disease in Germany: a cross-sectional survey. Zeitschrift für Gastroenterologie 59:10, pages 1068-1077.
Crossref
Heiner Raspe, Jana Langbrandtner & Angelika Hüppe. (2021) Medizinische Rehabilitation bei chronisch entzündlichen Darmerkrankungen: Zugang, Prozess und Ergebnisse. Die Rehabilitation 60:05, pages 320-329.
Crossref
Doreen Busingye, Allan Pollack & Kendal Chidwick. (2021) Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study. PLOS ONE 16:5, pages e0252458.
Crossref
Alicja Ewa Ratajczak, Aleksandra Szymczak-Tomczak, Anna Maria Rychter, Agnieszka Zawada, Agnieszka Dobrowolska & Iwona Krela-Kaźmierczak. (2021) Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases. Journal of Clinical Medicine 10:7, pages 1515.
Crossref
Hildegard Jasser‐Nitsche, Susanne Bechtold‐Dalla Pozza, Elisabeth Binder, Esther Bollow, Bettina Heidtmann, Young Hee Lee‐Barkley, Klemens Raile, Gideon Sousa, Ursula Schramm & Reinhard W. Holl. (2020) Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes. Acta Paediatrica 110:4, pages 1353-1358.
Crossref
Hassan Abdelnaby, NdeyeCoumba Ndiaye, Ferdinando D'Amico, AhmedMahmoud Fouad, Sameh Hassan, Alaa Elshafey, Wafaa Al Hashash, Mohammed Faisal, Yousef Alshamali, Talal Al-Taweel & Laurent Peyrin-Biroulet. (2021) NOD2/CARD15 polymorphisms (P268S, IVS8 +158 , G908R, L1007fs, R702W) among Kuwaiti patients with Crohn's disease: A case-control study . Saudi Journal of Gastroenterology 27:4, pages 249.
Crossref
Ulf Helwig, Karel Kostev & Carsten Schmidt. (2021) Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany. Journal of Clinical Gastroenterology 55:1, pages e1-e7.
Crossref
Ulf Helwig, Michael Mross, Stefan Schubert, Heinz Hartmann, Alina Brandes, Dara Stein, Christian Kempf, Jana Knop, Sarah Campbell-Hill & Robert Ehehalt. (2020) Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review. BMC Gastroenterology 20:1.
Crossref
Eva Baer, Daniel Jesper, Markus F. Neurath & Raja Atreya. (2020) Morbus Crohn und Colitis ulcerosa in der HausarztpraxisInflammatory bowel disease: differential diagnosis and medical care in GP practice. MMW - Fortschritte der Medizin 162:S3, pages 51-58.
Crossref
Johann Bartko, Berthold Reichardt, Roland Kocijan, Klaus Klaushofer, Jochen Zwerina & Martina Behanova. (2020) Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk After Hip Fracture. Journal of Crohn's and Colitis 14:9, pages 1256-1263.
Crossref
Sameh Hany Emile, Hayim Gilshtein & Steven D Wexner. (2020) Outcome of Ileal Pouch-anal Anastomosis in Patients With Indeterminate Colitis: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 14:7, pages 1010-1020.
Crossref
Min Zhu, Jing-Xi Mu, Ming-Shan Jiang, Arjudeb Mukherjee, Zhen Zeng, Yi-Ding Chen, Xiao-Li Yang & Hu Zhang. (2020) Chinese research into ulcerative colitis from 1978 to 2017: A bibliometric analysis. World Journal of Meta-Analysis 8:2, pages 163-172.
Crossref
Thomas Wilke, Antje Groth, Gráinne H. Long, Amanda R. Tatro & Diana Sun. (2020) Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany. Clinical Therapeutics 42:1, pages 130-143.e3.
Crossref
Antje Timmer. 2020. Chronisch-entzündliche Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen 13 50 .
Damián García-Olmo, Gert Van Assche, Ignacio Tagarro, Mary Carmen Diez, Marie Paule Richard, Javaria Mona Khalid, Marc van Dijk, Dimitri Bennett, Suvi R. K. Hokkanen & Julián Panés. (2019) Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database Analysis. Advances in Therapy 36:12, pages 3503-3518.
Crossref
Sang Hyoung Park, Ye-Jee Kim, Kyoung Hoon Rhee, Young-Ho Kim, Sung Noh Hong, Kyung Ho Kim, Seung In Seo, Jae Myung Cha, Sun Yong Park, Seung Kyu Jeong, Ji Hyun Lee, Hyunju Park, Joo Sung Kim, Jong Pil Im, Hyuk Yoon, Sung Hoon Kim, Jisun Jang, Jeong Hwan Kim, Seong O Suh, Young Kyun Kim, Byong Duk Ye & Suk-Kyun Yang. (2019) A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986–2015. Journal of Crohn's and Colitis 13:11, pages 1410-1417.
Crossref
Jussi Pohjonen, Rakel Nurmi, Martti Metso, Pia Oksanen, Heini Huhtala, Ilkka Pörsti, Jukka Mustonen, Katri Kaukinen & Satu Mäkelä. (2019) Inflammatory bowel disease in patients undergoing renal biopsies. Clinical Kidney Journal 12:5, pages 645-651.
Crossref
Lucia Albers, Rüdiger von Kries, Andreas Straube, Florian Heinen, Mirjam N Landgraf, Viola Obermeier & Ruth Ruscheweyh. (2019) Age- and sex-specific first health care use for migraine in 2016 in children and adolescents from prospectively collected health insurance data in Germany. Cephalalgia 39:9, pages 1156-1163.
Crossref
Lucia Albers, Rüdiger von Kries, Andreas Straube, Florian Heinen, Viola Obermeier & Mirjam N Landgraf. (2018) Do pre-school episodic syndromes predict migraine in primary school children? A retrospective cohort study on health care data. Cephalalgia 39:4, pages 497-503.
Crossref
James A King, Fox E Underwood, Nicola Panaccione, Josh Quan, Joseph W Windsor, Paulo G Kotze, Siew C Ng, Subrata Ghosh, Peter L Lakatos, Tine Jess, Remo Panaccione, Cynthia H Seow, Shomron Ben-Horin, Johan Burisch, Jean-Frédéric Colombel, Edward V LoftusJrJr, Richard Gearry, Jonas Halfvarson & Gilaad G Kaplan. (2019) Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development. The Lancet Gastroenterology & Hepatology 4:4, pages 287-295.
Crossref
Caroline Baehler, Beat Brüngger, Eva Blozik, Stephan R. Vavricka & Alain M. Schoepfer. (2019) Real-World Data on Topical Therapies and Annual Health Resource Utilization in Hospitalized Swiss Patients with Ulcerative Colitis. Inflammatory Intestinal Diseases 4:4, pages 144-153.
Crossref
Karel Kostev, Marcel Konrad & Louis Jacob. (2018) Time between suspected and confirmed diagnoses of Crohn’s disease and ulcerative colitis in patients followed in gastroenterological practices in Germany. International Journal of Colorectal Disease 33:7, pages 967-971.
Crossref
Caroline Bähler, Stephan R. Vavricka, Alain M. Schoepfer, Beat Brüngger & Oliver Reich. (2017) Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014. BMC Gastroenterology 17:1.
Crossref
Siew C Ng, Hai Yun Shi, Nima Hamidi, Fox E Underwood, Whitney Tang, Eric I Benchimol, Remo Panaccione, Subrata Ghosh, Justin C Y Wu, Francis K L Chan, Joseph J Y Sung & Gilaad G Kaplan. (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet 390:10114, pages 2769-2778.
Crossref
L. Ruokolainen, L. Paalanen, A. Karkman, T. Laatikainen, L. von Hertzen, T. Vlasoff, O. Markelova, V. Masyuk, P. Auvinen, L. Paulin, H. Alenius, N. Fyhrquist, I. Hanski, M. J. Mäkelä, E. Zilber, P. Jousilahti, E. Vartiainen & T. Haahtela. (2017) Significant disparities in allergy prevalence and microbiota between the young people in Finnish and Russian Karelia. Clinical & Experimental Allergy 47:5, pages 665-674.
Crossref
Gilaad G. Kaplan & Siew C. Ng. (2017) Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. Gastroenterology 152:2, pages 313-321.e2.
Crossref
Inge E. Deckers, Farida Benhadou, Marjolein J. Koldijk, Veronique del Marmol, Barbara Horváth, Jurr Boer, Hessel H. van der Zee & Errol P. Prens. (2017) Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study. Journal of the American Academy of Dermatology 76:1, pages 49-53.
Crossref
Ardythe L. Morrow & Ying Yu. 2017. Prebiotics and Probiotics in Human Milk. Prebiotics and Probiotics in Human Milk 207 222 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.